Stalevo 50-12.5-200 mg is a combination medication used to treat Parkinson's disease, containing Carbidopa, Levodopa, and Entacapone in a single tablet. It effectively enhances dopamine levels in the brain, improving motor function and providing a convenient dosage for patients.
Key Features
- Combination of three active ingredients for effective treatment
- Convenient single tablet dosage for ease of use
- Enhances dopamine levels to improve motor function
- Individualized dosing based on patient response
- Maximum daily dosage guidelines provided for safety
- Pack size: 30 film-coated tablets